Late side effects of chemotherapy in ovarian carcinoma: A cytogenetic, hematologic, and statistical study

Paclitaxel, cisplatin, and epirubicin fi

Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in Stage III and IV ovarian carcinoma : Long term results of a Phase II study

✍ Christos A. Papadimitriou; Lia A. Moulopoulos; Georgios Vlahos; Zannis Voulgaris 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Background: The combination of paclitaxel with cisplatin or carboplatin has become the preferred chemotherapy regimen in the treatment of epithelial ovarian carcinoma. anthracyclines also have activity in this disease. we conducted a phase ii study by using the combination of paclitaxel, cisplat